Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Summary
This is a phase II, single-center, open-label, trial to evaluate the diagnostic accuracy of PSMA-targeted 18F-DCFPyL PET/CT for detecting clinically significant prostate cancer in a screening population.
Official title: A Phase II Study to Evaluate the Performance of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer in Men With an Elevated PSA
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2018-03-29
Completion Date
2028-03-07
Last Updated
2026-03-30
Healthy Volunteers
No
Conditions
Interventions
18F-DCFPyL Injection
A bolus of \~9 mCi (333 MBq) of 18F-DCFPyL will be injected by slow IV push.
Locations (1)
SKCCC
Baltimore, Maryland, United States